Deals of the Year Six Other Notable Transactions of 2012 |
For other deal makers, results were mixed. Global equity issuance totaled $582.8 billion, down 7.5 percent from 2011, while revenue fell some 24 percent, to $12.03 billion, its lowest

Despite these trying conditions, the bankers celebrated in Institutional Investor's 2012 Rainmakers of the Year fetched handsome fees while making big things happen for their clients. This year's top ten list focuses on the largest pending and closed transactions of 2012 by total advisory fees, as estimated by investment consulting firm Freeman Consulting. The banks involved stand to earn some $850 million all told, a healthy increase over 2011's haul of $800 million.
Cross-border tie-ups loomed larger than ever, accounting for six of the ten deals. Asia asserted itself with two major prizes: the $20.1 billion purchase of U.S. cellular carrier Sprint Nextel Corp. by Japan's SoftBank Corp. (No. 2) and Chinese state-owned Cnooc Canada Holding's $17.7 billion acquisition of Canadian oil producer Nexen (No. 4). The buyer in the No. 1 transaction with its $45.8 billion takeover of miner Xstrata, Swiss commodities trader Glencore International also picked up Canuck grain handler and processor Viterra (No. 9). Uncertainty rules, but megadeals and global mergers are alive and well.
Deals of the Year Click on the Rainmakers below for more information on the deals.
Rank | Rainmaker | Acquirer | Seller | Closing Date | Deal Value ($ Millions) | Estimated Fees ($ Millions) |
1 | Michel Antakly & Team Morgan Stanley Tom Reid & Team | Glencore International | Xstrata | pending | $45,803 | $114 |
2 | Jeffrey Sine & Team Raine Group | SoftBank Corp. | Sprint Nextel Corp. | pending | 20,061 | 111 |
3 | Richard Girling & Team Centerview Partners | Walgreen Co. | Alliance Boots | Aug 2 | 21,362 | 107 |
4 | Peter Tague & Team Citigroup | Cnooc Canada Holding | Nexen | pending | 17,666 | 107 |
5 | Scott Lindsay, Charles Newton & Team Credit Suisse | Bristol-Myers Squibb Co. | Amylin Pharmaceuticals | Aug 9 | 6,862 | 84.7 |
6 | Michael Boublik & Team Morgan Stanley Alan Hartman & Team | Nestlé | Pfizer Nutrition | Nov 30 | 11,850 | 82 |
7 | Richard Campbell-Breeden & Team Goldman Sachs Group Hong Ping Yeo & Team | OUE Baytown TCC Assets* | Fraser & Neave | pending | 12,491 9,219 | 70 59 |
8 | David Kostel, Michael Muntner & Team Credit Suisse | WellPoint | Amerigroup Corp. | pending | 4,852 | 60 |
9 | Philip Evershed & Team Canaccord Genuity | Glencore International | Viterra | Dec 7 | 7,362 | 58 |
10 | Richard Jacobsen Jr. & Team Greenhill & Co. | Aetna | Coventry Health Care | pending | 5,695 | 56 |
*Competing bids | Source: Thomson Reuters/Freeman Consulting. |